Adherence, satisfaction, and quality of life in Wilson disease patients after switching to trientine tetrahydrochloride: observational data from a dual cohort study
Adults with WD on maintenance therapy following a switch in therapy to TETA 4HCl some improvements in adherence, satisfaction and QoL were observed.
Authors
- Fabio Tedone (ORCID: https://orcid.org/0000-0002-0094-8825)
- Andrea Crosignani
- Valentina Medici (ORCID: https://orcid.org/0000-0001-5438-284X)
- Pier Maria Battezzati (ORCID: https://orcid.org/0000-0003-1344-3452)
- Stefania Lopatriello
- R. D’Incà (ORCID: https://orcid.org/0000-0003-1169-1890)
- Nora Cazzagon (ORCID: https://orcid.org/0000-0002-6937-8664)
- Alberto Civolani
- Massimo Zuin (ORCID: https://orcid.org/0000-0003-3906-4362)
- Emanuela Bonaiuto
- Emanuela Vargiu
Institutions
- AOL (United States) (US)
- University of Padua (IT)
- University of Cagliari (IT)
- University of Milan (IT)
- Azienda Ospedale - Università Padova (IT)
- University of Florence (IT)
- University of California, Davis (US)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-10-23
- DOI
- https://doi.org/10.3389/fphar.2025.1515686
- Primary Topic
- Trace Elements in Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00